Amidst the unfolding AI revolution, astute investors are looking for high potential tech companies that are at the forefront of AI utilization. One I found is MedBright AI Investments (Ticker: MBAI.c or MBAIF for US investors), a pioneering force in AI-driven innovations tailored for efficient healthcare.
At the forefront of innovation, MedBright AI leverages its "Medmatrix" platform, harnessing the power of AI and historical data encompassing medical, credit card, and driving records. This data amalgamation empowers the platform to forecast optimal appointment durations for clinic patients, revolutionizing scheduling for doctors and enhancing the overall patient experience.
Today, MBAI closed up 10% on above-average volume.
MBAI's solution addresses a substantial challenge in healthcare, particularly the inefficiencies prevalent in doctor's waiting rooms, marking it as a noteworthy venture.
The potential impact of MedBright AI Investments extends well beyond immediate gains. In the expansive $2.2 trillion healthcare market, the "Medmatrix" platform is anticipated to boost efficiency by 10%, representing a significant $220 billion opportunity.
The timing of this solution aligns with a pivotal moment in AI capabilities, reaching a level where processing vast datasets enables accurate predictions, a feat previously deemed unattainable.
Company deck here: https://assets-global.website-files.com/654400b037e09f716a28c32b/655f911132d0b133ffc9ca1c_Medbright%20Q4%202023%20Investor%20Presentation.pdf
Posted on behalf of MedBright AI Investments Inc.